24 results for “symposium”
Europe’s dedicated medical cannabis education series for clinicians and industry professionals announces two autumn events — 4 November at Mainhaus, Frankfurt, and 26 November at Conway Hall, London
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the […]
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s […]
Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
Cannabis Health will host its first expert-led educational event for healthcare professionals later this year.
Researchers concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions.
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains, and the dramatic swing towards higher THC products.
Chancellor Rachel Reeve’s recent budget announcement is yet to be fully digested, and the implications for UK businesses and the wider public are still being analysed. However, one thing remains […]
The authors say the guidance aims to address “clear gaps” in prescriber training and education.
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field […]
A quick rundown of the highlights so far, and what’s still left to look forward to.
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also where progress is still […]
The event brought together expert medical and scientific voices and powerful patient perspectives.
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers […]
In her new bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging […]
From endometriosis and chronic pelvic pain to PMDD and menopause, more women are turning to cannabis-based medicine, but what do we know and where do we still need more research? […]
We unpack the science behind the ECS and its significance in a range of chronic conditions.
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development […]
Almost seven years since medical cannabis was legalised in the UK on 1st November 2018, less than 1% of the UK’s approximate 100,000 doctors on the General Medical Council (GMC) […]
We examine the research and real-world evidence behind the use of cannabis-based medicines in psychiatry.
A number of studies have explored whether medicinal cannabis could be used to treat some of the common symptoms.
Is regulators’ focus on randomised controlled trials holding back progress in medical cannabis research?
Dr Sue Clenton, Medical Director of Releaf cannabis clinic explains what it takes to go from a few hundred to thousands of patients, without compromising on the quality of care. […]
New guidelines aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK.
